ClinicalTrials.gg
RecruitingNCT03526029Updated Feb 19, 2025

Swiss Trauma Registry

An observational study in Trauma, Multiple and Trauma, sponsored by University Hospital, Basel, Switzerland. Recruiting at 12 sites in Switzerland. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2025-02-19.

Sponsored by University Hospital, Basel, Switzerland · Observational

From the registry’s dates

  • Started Jan 2015; still recruiting 11 years 10 months later.
Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
2,000
Ages
16 Years and older
Sex
All
01

Study summary

The Swiss Conference of Cantonal Health Directors has transferred the planning of highly specialized medicine to a specialized body under the direction of the Swiss Academy of Sciences. This specialist body has defined the treatment of critically ill as part of highly specialized medicine and founded the Swiss Trauma Registry at 12 hospitals in Switzerland. The registry is designed to provide a consistent and standardized approach and treatment outcomes in the short and long term quality control and as a basis for planning highly specialized medicine.

02

Conditions studied

  • Trauma, Multiple
  • Trauma
03

In context

Multiple Trauma

139 studies on the registry are indexed under Multiple Trauma; 32 are open to participants now.

This study's planned enrollment of 2,000 is above the median of 200 across 84 observational studies indexed under Multiple Trauma.

Browse Multiple Trauma studies →

Lead sponsor

University Hospital, Basel, Switzerland is the lead sponsor of 990 studies on the registry; 189 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

severely injured patients at hospitals

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • injury severity code > 16 and 7 or abbreviated injury scale >3 for region of skull and brain

Exclusion criteria

Exclusion Criteria:

  • patients who will transferred in a burn unit
  • drowned patients
05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
2,000 participants (estimated)
Target follow-up
5 Years
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. mortality in severely injured patients

    number of severely injured patients who died

    Time frame: day of injury until year 5

  2. patterns of injuries in severely injured patients

    comparison of patterns of injuries in severely injured patients

    Time frame: day of injury until year 5

  3. Duration of primary hospitalisation after initial injury measured by days

    Duration of primary hospitalisation after initial injury measured by days

    Time frame: day of injury until year 5

  4. Duration of secondary hospitalisation after initial injury measured by days

    Duration of secondary hospitalisation after initial injury measured by days

    Time frame: day of injury until year 5

  5. Treatment costs in Swiss Francs

    Treatment costs in Swiss Francs

    Time frame: day of injury until year 5

  6. line of treatments due to the initial injury (kind of treatment)

    line of treatments due to the initial injury (kind of treatment)

    Time frame: day of injury until year 5

  7. line of treatments due to the initial injury (timepoints of treatments)

    line of treatments due to the initial injury (timepoints of treatments)

    Time frame: day of injury until year 5

  8. Duration of Rehabilitation measured by days

    Duration of Rehabilitation measured by days

    Time frame: day of injury until year 5

  9. Duration of incapacity for work measured by days

    Duration of incapacity for work measured by days

    Time frame: day of injury until year 5

  10. diagnostic efforts measured by number and timepoint of imaging

    number and timepoint of imaging

    Time frame: day of injury until year 5

  11. treatment efforts measured by number of medication given

    number and timepoint of medication given and medical interventions performed

    Time frame: day of injury until year 5

  12. Primary supply Dates measured in minutes

    Primary supply Dates measured by time to start of surgery, time to admission to trauma room, time to ICU admission

    Time frame: on day of primary hospitalisation

  13. treatment efforts measured by number of medical interventions performed

    Treatment efforts measured by number and timepoint of medication given and medical interventions performed

    Time frame: day of injury until year 5

  14. treatment efforts measured by timepoint of medication given

    Treatment efforts measured by number and timepoint of medication given and medical interventions performed

    Time frame: day of injury until year 5

  15. treatment efforts measured by timepoint of medical interventions performed

    Treatment efforts measured by number and timepoint of medication given and medical interventions performed

    Time frame: day of injury until year 5

07

Study locations

12 of 12 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03526029
Responsible party
Sponsor
First posted
May 16, 2018
Start date
Jan 1, 2015
Primary completion
Dec 31, 2040 (estimated)
Completion
Dec 31, 2040 (estimated)
Last update
Feb 19, 2025

Study contacts

Nicolas Bless, Prof MD
Contact
nicolas.bless@usb.ch
Dario Picardi
Contact
ilona.ahlborn@usb.ch
Andreas Marc Müller, Prof MD
principal investigator · University Hospital, Basel, Switzerland

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion